SLNO Gross Margin

The Gross Margin of Soleno Therapeutics Inc (SLNO) is 98.58%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SLNO Gross Margin - Historical Value

Date	Value
2025-12-31	98.58%

SLNO Gross Margin - Peers Comparison

Ticker	Name	Value
VRTX	Vertex Pharmaceuticals Inc	86.24%
AIKI	Aikido Pharma Inc	100.00%
EVAX	Evaxion A/S	7775.20%
QLGN	Qualigen Therapeutics Inc	13.65%
MACK	Merrimack Pharmaceuticals Inc	-194.15%
REGN	Regeneron Pharmaceuticals Inc	86.56%
WLLW.TO	Atlas Energy Corp	-809.99%
950160.KQ	Kolon TissueGene Inc	11.72%
AMGN	Amgen Inc	82.52%
SCPS	Scopus Biopharma Inc	7775.20%
SYN	Synthetic Biologics Inc	85.44%
APRE	Aprea Therapeutics Inc	7775.20%
CWBR	CohBar Inc	7775.20%
RGRX	RegeneRx Biopharmaceuticals Inc	100.00%
ANIX	Anixa Biosciences Inc	97.00%
ATNM	Actinium Pharmaceuticals Inc	100.00%
HBP.TO	Helix BioPharma Corp	63.80%
MNPR	Monopar Therapeutics Inc	7775.20%
PDSB	PDS Biotechnology Corp	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
ABBV	AbbVie Inc	71.62%
ADXS	Ayala Pharmaceuticals Inc	-
TCON	TRACON Pharmaceuticals Inc	7775.20%
CRVS	Corvus Pharmaceuticals Inc	7775.20%
DFFN	Diffusion Pharmaceuticals Inc	100.00%
GILD	Gilead Sciences Inc	78.84%
LUMO	Lumos Pharma Inc	7775.20%
SZLS.TO	StageZero Life Sciences Ltd	-10.53%
950200.KQ	Psomagen Inc	21.92%
MRZM	Marizyme Inc	70.87%
SLS	Sellas Life Sciences Group Inc	90.00%
CLGN	Collplant Biotechnologies Ltd	-160.00%
CYCN	Cyclerion Therapeutics Inc	7775.20%
MRNA	Moderna Inc	70.32%